We’re proud to share that our Co-founder and Head of Scientific Programs, Dr. Atharva Karulkar, paneled a session at the World Health Summit Regional Meeting 2025 in New Delhi. Dr. Karulkar was invited to share his insights during a thought-provoking session titled "How to

At #CARTSummit2025, Dr. Rajeev Raghuvanshi, Drugs Controller General of India (DCGI), Central Drugs Standard Control Organization (CDSCO), delivered a forward-looking session titled “Advanced Healthcare: Can India Lead the Way for Cell and Gene Therapy in the Next Decade?” He

Durable, deep, and life-changing – Our CAR-T cell therapy (NexCAR19) continues to demonstrate real-world impact. We’re proud to see our first patient at Aster MIMS still in remission months after treatment. Durability isn't just a clinical metric, it's a second chance at life.

At #CARTSummit2025, Mr. Shirish Arya, our Co-founder and Director of Corporate Strategy and Business Development at ImmunoACT, delivered an insightful session titled “Innovating for Impact: Building Scalable, Affordable, and Accessible CAR-T Cell Therapy in India.” He

At #CARTSummit2025, Ms. Shalini Jatia, Officer in Charge at ImPaCCT Foundation, Tata Memorial Centre, led a powerful session titled “Patient Journey: Learning the Patient's Journey in the Patient's Own Voice.” The session brought to the stage eight CAR-T therapy recipients who

Excited to see our founder and IIT Bombay Prof. Rahul Purwar (Rahul Purwar ) share the incredible journey of India’s first homegrown CAR-T cell therapy tomorrow at DBT-THSTI! #NationalTechnologyDay #MakeInIndia #CARTcell #ImmunoACT #NexCAR19

At #CARTSummit2025, the session titled “Bridging the Gap - Role of NGOs and CSR in Providing Intent-to-Cure Solutions for Cancer Care” brought together experts from healthcare and the development sector to address access challenges in cancer treatment. Moderated by Ms. Sunita

On 𝗪𝗼𝗿𝗹𝗱 𝗕𝗹𝗼𝗼𝗱 𝗖𝗮𝗻𝗰𝗲𝗿 𝗗𝗮𝘆, we are hosting a special webinar featuring two renowned experts in hematology. Dr. Rahul Bhargava, Fortis Hospital will speak on strategies to improve access to CAR-T cell therapy in India. This will be followed by Dr Kunal Goyal

𝗪𝗼𝗿𝗹𝗱 𝗕𝗹𝗼𝗼𝗱 𝗖𝗮𝗻𝗰𝗲𝗿 𝗗𝗮𝘆 𝗦𝗲𝗿𝗶𝗲𝘀 | 𝗗𝗮𝘆 𝟭 – 𝗟𝗲𝘁’𝘀 𝗧𝗮𝗹𝗸 𝗔𝗯𝗼𝘂𝘁 𝗟𝘆𝗺𝗽𝗵𝗼𝗺𝗮 Behind every cancer statistic is a person, a family, a story. In India, over 𝟯𝟵,𝟬𝟬𝟬 people are diagnosed with lymphoma each year - and 𝟮𝟮,𝟬𝟬𝟬 don’t make

𝗪𝗼𝗿𝗹𝗱 𝗕𝗹𝗼𝗼𝗱 𝗖𝗮𝗻𝗰𝗲𝗿 𝗗𝗮𝘆 𝗦𝗲𝗿𝗶𝗲𝘀 | 𝗗𝗮𝘆 𝟮 – 𝗟𝗲𝘁’𝘀 𝗧𝗮𝗹𝗸 𝗔𝗯𝗼𝘂𝘁 𝗟𝗲𝘂𝗸𝗲𝗺𝗶𝗮 Beyond the diagnosis is a childhood on pause, and a future worth fighting for. Yet, Acute Lymphoblastic Leukemia (ALL) accounts for 25% of all childhood cancers in

𝗪𝗼𝗿𝗹𝗱 𝗕𝗹𝗼𝗼𝗱 𝗖𝗮𝗻𝗰𝗲𝗿 𝗗𝗮𝘆 𝗦𝗲𝗿𝗶𝗲𝘀 | 𝗗𝗮𝘆 𝟯 – 𝗔 𝗡𝗲𝘄 𝗘𝗿𝗮 𝗼𝗳 𝗛𝗼𝗽𝗲 Not all battles are visible - but every one of them deserves a powerful ally. For patients with blood cancers who’ve exhausted conventional treatments, there’s now a breakthrough

𝗪𝗲’𝗿𝗲 𝗟𝗶𝘃𝗲! 𝗣𝗿𝗲𝘀𝗲𝗻𝘁𝗶𝗻𝗴 𝘁𝗵𝗲 𝗔𝗹𝗹-𝗡𝗲𝘄 𝗜𝗺𝗺𝘂𝗻𝗼𝗔𝗖𝗧 𝗪𝗲𝗯𝘀𝗶𝘁𝗲 Our new website is here - with a fresh design, smoother navigation, and everything you need to know about our CAR-T journey. Explore our product pipeline, learn more about #NexCAR19,

Our Founder, Prof. Rahul Purwar (Rahul Purwar), will be attending the 𝗘𝗛𝗔 𝟮𝟬𝟮𝟱 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀, a premier gathering in the field of hematology, taking place in Milan, Italy. 📅 June 12–15, 2025 📍 Milan, Italy Prof. Purwar will be present to connect with global

We are happy to share that Dr. Sushant Kumar, Senior Scientist at #ImmunoACT, recently delivered an inspiring lecture at IIT Bombay to the National-level winners of Vidyarthi Vigyan Manthan (VVM) - India’s premier science talent program for VI-XI school students. His talk,

At ImmunoACT, we believe CAR-T cell therapy is more than just medicine - it’s a personalized revolution in the fight against cancer. In this exclusive video, our medical expert Dr. Sameer Melinkeri from Deenanath Mangeshkar Hospital and Research Center (Deenanath Mangeshkar Hospital And Research Center)

𝗙𝗿𝗼𝗺 𝘃𝗶𝘀𝗶𝗼𝗻 𝘁𝗼 𝘃𝗮𝗹𝗶𝗱𝗮𝘁𝗶𝗼𝗻 - our journey in pioneering CAR-T in India is now a profitable one. Grateful for the persistence, passion, and purpose that drives our mission to make advanced therapies accessible. 🔗economictimes.indiatimes.com/industry/healt… #CAR_TCellTherapy

𝗪𝗲'𝘃𝗲 𝗦𝗲𝗰𝘂𝗿𝗲𝗱 𝗮 𝗨𝗦 𝗣𝗮𝘁𝗲𝗻𝘁 𝗳𝗼𝗿 𝗡𝗲𝘅𝗖𝗔𝗥𝟭𝟵™ (𝘁𝗮𝗹𝗶𝗰𝗮𝗯𝘁𝗮𝗴𝗲𝗻𝗲 𝗮𝘂𝘁𝗼𝗹𝗲𝘂𝗰𝗲𝗹), 𝘁𝗵𝗲 𝗪𝗼𝗿𝗹𝗱’𝘀 𝗙𝗶𝗿𝘀𝘁 𝗛𝘂𝗺𝗮𝗻𝗶𝘀𝗲𝗱 𝗖𝗔𝗥-𝗧 𝗖𝗲𝗹𝗹 𝗧𝗵𝗲𝗿𝗮𝗽𝘆 𝗳𝗿𝗼𝗺 𝗜𝗻𝗱𝗶𝗮! At #ImmunoACT, India’s homegrown pioneer in cell

At #ImmunoACT, we believe that effective counselling is the first step in a patient’s CAR-T journey - helping families move forward with clarity, confidence, and hope. In this expert talk, Dr. Esha Kaul (Director, Haematology, Hemato-Oncology & Bone Marrow Transplant, Max

Our Founder, Prof. Rahul Purwar , will be representing ImmunoACT at the Fifth Innovative Therapies Days 2025: An International Symposium, taking place in Besancon, France. 📅 October 9–10, 2025 📍 Kursaal, Besancon, France Prof. Purwar will be sharing the inspiring "Journey of

It all began with a vision to make cutting-edge therapies accessible to every patient who needs them. Today, #NexCAR19 stands as a symbol of that vision realized, a humanized, single-dose CAR-T therapy with ~98% manufacturing success and up to 90% cost reduction for patients